Esteve Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsEsteve Pharmaceuticals

Esteve Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Nodetrip (previously xeristar)	Duloxetine	2004-12-17	2037	Neuralgia , Diabetic neuropathies , Musculoskeletal pain , Anxiety disorders , Major depressive disorder , Stress urinary incontinence , Diabetes mellitus
Prialt	Ziconotide	2004-12-28		Pain , Chronic pain , Spinal injections
Thiotepa riemser	Thiotepa	2021-03-26		Breast neoplasms , Ovarian neoplasms , Sarcoma , Lymphoma , Urinary bladder neoplasms , Hematopoietic stem cell transplantation , Adenocarcinoma , Neoplasms
Metopirone	Metyrapone	1982-01-01		—
Lysodren	Mitotane	1982-01-01		Adrenal cortex neoplasms, Adrenocortical carcinoma, Cushing syndrome
Quzyttir	Cetirizine	2019-10-04	2030-2032	Allergic rhinitis perennial, Urticaria, Sinusitis, Asthma, Common cold

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use